FM
KZR

Frazier Management’s Kezar Life Sciences KZR Stock Holding History

Frazier Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,058
Closed -$363K – 26
2019
Q4 		$363K Sell
9,058
-37,716
-81% -$1.16M 0.06% 20
2019
Q3 		$1.53M Hold
46,774
– – 0.48% 17
2019
Q2 		$3.61M Buy
46,774
+9,766
+26% +$1.52M 0.92% 16
2019
Q1 		$6.57M Buy
37,008
+12,008
+48% +$2.37M 1.58% 15
2018
Q4 		$5.9M Hold
25,000
– – 1.52% 13
2018
Q3 		$5.35M Hold
25,000
– – 0.98% 16
2018
Q2 		$4.33M Buy
+25,000
New +$4.36M 0.9% 13

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Frazier Management's KZR Position: Q1 2020 in Review

Frazier Management sold out of Kezar Life Sciences (KZR) in Q1 2020, closing a stake of 9,058 shares — an estimated $363K sold.

Frazier Management first reported a position in KZR in Q2 2018 and held it in 7 quarters. The position peaked at $6.57M in Q1 2019. 59 funds tracked by Wall St. Rank hold KZR as of Q1 2020.

  • Frazier Management reported no remaining Kezar Life Sciences position as of Q1 2020 after selling out during the quarter.
  • Frazier Management sold 9,058 Kezar Life Sciences shares in Q1 2020, an estimated $363K.
  • Frazier Management first reported a position in Kezar Life Sciences in Q2 2018 and held it in 7 quarters.
  • Frazier Management's Kezar Life Sciences position peaked at $6.57M in Q1 2019.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2020.

Based on Frazier Management's 13F filing for Q1 2020, filed 13 May 2020.